Wang Y - Search Results

1

Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T. Wang Y, et al. Clin Cancer Res. 2008 Jun 1;14(11):3607-16. doi: 10.1158/1078-0432.CCR-07-2020. Clin Cancer Res. 2008. PMID: 18519795

2

Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.

Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T. Pakunlu RI, et al. Among authors: wang y. Cancer Res. 2004 Sep 1;64(17):6214-24. doi: 10.1158/0008-5472.CAN-04-0001. Cancer Res. 2004. PMID: 15342407

3

A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug.

Wang Y, Minko T. Wang Y, et al. Biochem Pharmacol. 2004 Nov 15;68(10):2031-42. doi: 10.1016/j.bcp.2004.07.017. Biochem Pharmacol. 2004. PMID: 15476674

4

Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis.

Wang Y, Pakunlu RI, Tsao W, Pozharov V, Minko T. Wang Y, et al. Mol Pharm. 2004 Mar-Apr;1(2):156-65. doi: 10.1021/mp034031n. Mol Pharm. 2004. PMID: 15832512

5

Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.

Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T. Dharap SS, et al. Among authors: wang y. J Pharmacol Exp Ther. 2006 Mar;316(3):992-8. doi: 10.1124/jpet.105.094243. Epub 2005 Nov 15. J Pharmacol Exp Ther. 2006. PMID: 16291730

6

Novel polymeric prodrug with multivalent components for cancer therapy.

Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T. Khandare JJ, et al. Among authors: wang y. J Pharmacol Exp Ther. 2006 Jun;317(3):929-37. doi: 10.1124/jpet.105.098855. Epub 2006 Feb 9. J Pharmacol Exp Ther. 2006. PMID: 16469865

7

JNK1 as a molecular target to limit cellular mortality under hypoxia.

Betigeri S, Pakunlu RI, Wang Y, Khandare JJ, Minko T. Betigeri S, et al. Among authors: wang y. Mol Pharm. 2006 Jul-Aug;3(4):424-30. doi: 10.1021/mp060014x. Mol Pharm. 2006. PMID: 16889436

8

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.

Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. Pakunlu RI, et al. Among authors: wang y. J Control Release. 2006 Aug 28;114(2):153-62. doi: 10.1016/j.jconrel.2006.06.010. Epub 2006 Jun 15. J Control Release. 2006. PMID: 16889867

9

New generation of liposomal drugs for cancer.

Minko T, Pakunlu RI, Wang Y, Khandare JJ, Saad M. Minko T, et al. Among authors: wang y. Anticancer Agents Med Chem. 2006 Nov;6(6):537-52. doi: 10.2174/187152006778699095. Anticancer Agents Med Chem. 2006. PMID: 17100558 Review.

10

Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment.

Jayant S, Khandare JJ, Wang Y, Singh AP, Vorsa N, Minko T. Jayant S, et al. Among authors: wang y. Pharm Res. 2007 Nov;24(11):2120-30. doi: 10.1007/s11095-007-9406-1. Epub 2007 Aug 1. Pharm Res. 2007. PMID: 17668297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299,824 results

Search Page

Filters